人äºã§ã·ã¹ãã å°å ¥å¢å ãDXæšé²æŽŸã75%ã« - ç®æšç®¡çãè©äŸ¡ã人æç®¡çãããŒã«ã§å¹çãã

ç®æ¬¡ãéãã
- ã³ããã§ã人äºéšéã®èª²é¡ã¯å€ãããªã
- 人äºé åã§ãDXãéèŠäºé ã«
- é«ãŸãããžã¿ã«ãžã®æåŸ
- 人äºåãã·ã¹ãã å°å ¥ãå¢å
- ã¿ã¬ã³ããããžã¡ã³ãã®çŸç¶
- èªç¥åºŠã¯9å²ä»¥äž
- éçšçã¯2岿¢ãŸã
- 人æç®¡çãžã®ããžã¿ã«æŽ»çšã課é¡ã¯ïŒ
- 人äºã®DXã¯ãŸã ãããã
ã³ããã§ã人äºéšéã®èª²é¡ã¯å€ãããªã
çµæžæŽ»åã®æšé²ãšæ°åã³ãããŠã€ã«ã¹ææçïŒCOVID-19ïŒæ¡å€§ã®é²æ¢ãäž¡ç«ãããããšãäŒæ¥ã¯äºæ¥ãæ¢ããã«åŸæ¥å¡ã顧客ã®å®å šã確ä¿ããæ¹æ³ã暡玢äžã§ãããã¬ã¯ãŒã¯ïŒãªã¢ãŒãã¯ãŒã¯ïŒã«ããåšå® å€åãããªãã£ã¹å€åã䜵çšãããã€ããªããã¯ãŒã¯ãªã©ãæ°ããåãæ¹ã詊ã¿ãããŠããŸãã
åãç°å¢ã«å€é©ã®æ³¢ãæŒãå¯ããŠããŸããã人äºåéã®éèŠèª²é¡ã«å€åã¯ãªãããã§ããäŒæ¥ã®äººäºéšéã察象ãšããã¢ãã©ãšã®èª¿æ»ã«ãããšãã³ããçŠã®çŸåšã1幎åãšåæ§ãããããŒãžã£ãŒå±€ã»ç®¡çè·ã®è²æãã§ããŠããªãããåªç§ãªäººæãèŸããŠããŸããããšã«æ©ãã§ããäŒæ¥ãå€ãã¿ãããŸããã
èª²é¡ | 2019幎 | 2020幎 |
---|---|---|
ãããŒãžã£ãŒå±€ã»ç®¡çè·ã® è²æãã§ããŠããªã |
47.7ïŒ | 46ïŒ |
åªç§ãªäººæãèŸããŠããŸã | 38.7ïŒ | 36ïŒ |
â»ã¢ãã©ãšãã調æ»çµæã人äºé åã«ãããDXå éïŒããå ã«äœæ
ãŸãããã¬ã¯ãŒã¯ã§çŽæ¥é¡ãåãããæ©äŒãæžã£ã圱é¿ã§ãããã¬ã¯ãŒã¯ç°å¢äžã§ã³ãã¥ãã±ãŒã·ã§ã³éãæžã£ãŠãããïŒ30.7ïŒ ïŒãããã¬ã¯ãŒã¯ç°å¢äžã§ã®è©äŸ¡æ¹æ³ãåãããªããïŒ28.7ïŒ ïŒãšããæ©ã¿ãç®ç«ã¡ãŸãã
åºå
žïŒã¢ãã©ãš / ã調æ»çµæã人äºé åã«ãããDXå éïŒ
人äºé åã§ãDXãéèŠäºé ã«
人äºåéã®èª²é¡ã¯å€ãããååšããŠãããã®ã®ãåãç°å¢ã䟡å€èгã¯COVID-19ã«ãã£ãŠæ¿å€ããŸãããã¢ãã©ãšã¯ããã®ç¶æ³ã§èª²é¡ã解決ããããã«ã人äºé åã®ããžã¿ã«ãã©ã³ã¹ãã©ãŒã¡ãŒã·ã§ã³ïŒDXïŒæŽ»çšãéèŠãšææããŠããŸãã
é«ãŸãããžã¿ã«ãžã®æåŸ
課é¡ã®è§£æ±ºã«æå¹ã ãšèãããã察çã«ã€ããŠå°ãããšããã2019幎ã®èª¿æ»ãšåããã瀟å¡ãšã®é¢è«ã»1on1ããŒãã£ã³ã°ãïŒ52.4ïŒ ïŒããç ä¿®ã»æè²å¶åºŠã®å å®ãïŒ50.9ïŒ ïŒããåŸ éæ¹åãïŒ41ïŒ ïŒãããã3ã§ãã
ãã ãã4äœã«ã¯ã泚ç®ããã€ã€ããæ¥çžŸè©äŸ¡å¶åºŠãOKRïŒObjectives and Key ResultsïŒããå«ããç®æšç®¡çã»OKRé¢é£ãµãŒãã¹ã»ã·ã¹ãã ã®å°å ¥ãïŒ38.7ïŒ ïŒãå ¥ããŸãããããããåå¹Žã«æ¯ã¹8ãã€ã³ã以äžãå¢ããŠããŠãæåŸ ãé«ãŸã£ãŠããããã§ãã
åºå
žïŒã¢ãã©ãš / ã調æ»çµæã人äºé åã«ãããDXå éïŒ
人äºåãã·ã¹ãã å°å ¥ãå¢å
察çã®å®æœç¶æ³ã«ã€ããŠã¯ãã瀟å¡ãšã®é¢è«ã»1on1ããŒãã£ã³ã°ãïŒ47.2ïŒ ïŒãšäžŠã³ããç®æšç®¡çã»OKRé¢é£ãµãŒãã¹ã»ã·ã¹ãã ã®å°å ¥ãïŒ33ïŒ ïŒã®å¢å ãç®ç«ã¡ãŸãã
ãŸãããåŸæ¥å¡ãµãŒãã€é¢é£ãµãŒãã¹ã»ã·ã¹ãã å°å ¥ãïŒ27.9ïŒ ïŒããã¿ã¬ã³ããããžã¡ã³ãé¢é£ãµãŒãã¹ã»ã·ã¹ãã å°å ¥ãïŒ27.9ïŒ ïŒãå¢ããŠããŠã人äºé åã§DXã«ç©æ¥µçãªäŒæ¥ãå¢å ãããšããããšã§ãã
ã¿ã¬ã³ããããžã¡ã³ãã·ã¹ãã åŸ¹åºæ¯èŒ | éžå®ãã€ã³ãã
ç¡æãã䜿ããOKR管çããŒã« | ç®æšèšå®äºäŸã€ã
1on1ã®ç®çã¯ïŒããããã®æ¯æŽããŒã«ãšå®è·µæ¹æ³
åºå
žïŒã¢ãã©ãš / ã調æ»çµæã人äºé åã«ãããDXå éïŒ
ã¿ã¬ã³ããããžã¡ã³ãã®çŸç¶
COVID-19察çã§ãçŽæ¥ã³ãã¥ãã±ãŒã·ã§ã³å¯èœãªæ©äŒãæžã£ãŠããŸãããã®ããã人æãå¹çãã管çããã·ã¹ãã ã®éèŠæ§ã匷ãèªèãããããã«ãªããŸããã
1幎åã®èª¿æ»ã«ãªããŸãããProFutureã®ãHRç·ç ïŒãã¿ã¬ã³ããããžã¡ã³ãã·ã¹ãã ãã«é¢ããã¢ã³ã±ãŒã調æ»ãã§ãã¿ã¬ã³ããããžã¡ã³ãã®èªç¥åºŠããå¿ èŠãªã·ã¹ãã ããµãŒãã¹ã®å°å ¥ç¶æ³ã確èªããŸãããã
èªç¥åºŠã¯9å²ä»¥äž
ãã¿ã¬ã³ããããžã¡ã³ãããšããæŠå¿µããç¥ã£ãŠãããäŒæ¥ã¯66ïŒ ããããèããããšããããäŒæ¥ã®26ïŒ ãå ãããšãèªç¥åºŠã¯9å²ä»¥äžã«ãªããŸããã
åºå
žïŒProFuture / HRç·ç ïŒãã¿ã¬ã³ããããžã¡ã³ãã·ã¹ãã ãã«é¢ããã¢ã³ã±ãŒã調æ»ãçµæå ±å
ãããŠãã¿ã¬ã³ããããžã¡ã³ããæšé²ããããšã«ã€ããŠã¯ããéèŠãªäººäºèª²é¡ã®äžã€ã§ãããã42ïŒ ããç¹ã«éèŠãªäººäºèª²é¡ã§ãããã15ïŒ ãšãéèŠèŠããäŒæ¥ãéåæ°ã«äžããŸãããã ããéèŠèŠãããšã®åçã¯èŠæš¡ã®å€§ããªäŒæ¥ã»ã©é«ããªããŸãããäžå°äŒæ¥ã§ã¯ã人ã®é¡ãèŠããŠåŸæ¥å¡ã®èœåãææ¡ããããããšãããã¿ã¬ã³ããããžã¡ã³ãã®å¿ èŠæ§ãäœãã®ãããããŸããã
åºå
žïŒProFuture / HRç·ç ïŒãã¿ã¬ã³ããããžã¡ã³ãã·ã¹ãã ãã«é¢ããã¢ã³ã±ãŒã調æ»ãçµæå ±å
éçšçã¯2岿¢ãŸã
å®éã®ã¿ã¬ã³ããããžã¡ã³ãéçšçã¯ãèªç¥åºŠã®é«ããšéèŠèŠãããŠããç¶æ³ã«ããããããã21ïŒ ãšé«ããããŸããããã£ãšãå€ãåçã¯ããé¢å¿ã¯ããããéçšããŠããªããã®52ïŒ ã§ãããäŒæ¥ã®èŠæš¡å¥ã§ã¯ãåŸæ¥å¡æ°ã1,001å以äžã ãš36ïŒ ã301åãã1,000åã ãš27ïŒ ã300å以äžã ãš9ïŒ ã§ããã¯ã倧ããªäŒæ¥ã»ã©ã¿ã¬ã³ããããžã¡ã³ãã®å¿ èŠæ§ãé«ãŸãããã§ãã
åºå
žïŒProFuture / HRç·ç ïŒãã¿ã¬ã³ããããžã¡ã³ãã·ã¹ãã ãã«é¢ããã¢ã³ã±ãŒã調æ»ãçµæå ±å
ãªããå°å ¥ããã¿ã¬ã³ããããžã¡ã³ãã·ã¹ãã ã®éžå®åºæºã¯ã65ïŒ ã®ãéçšã³ã¹ããã51ïŒ ã®ãåæã³ã¹ãããäžäœã«äžŠã³ãŸããããã®ããšãããäºç®ã®éãããäžå°äŒæ¥ã¯ããšãå¿ èŠæ§ãæããŠãå°å ¥ã«èžã¿åããªããšãããå€ããšèããããŸãã
人æç®¡çãžã®ããžã¿ã«æŽ»çšã課é¡ã¯ïŒ
ã¿ã¬ã³ããããžã¡ã³ãã·ã¹ãã ãªã©ãå°å ¥ããããšãããšãäºç®ã®å£ãç«ã¡ã¯ã ãããŸãããã®å£ãå£ããŠäººäºDXãæšé²ããã«ã¯ãçµå¶è ã®çè§£ãšååãæ¬ ãããŸããã
ããŒãœã«ç·åç ç©¶æã調ã¹ããšããã人æãããžã¡ã³ãã«å¯Ÿããããžã¿ã«æŽ»çšãžã®é¢å¿ã¯é«ãã®ã§ãããäºç®ã®ç¢ºä¿ãçµå¶ãããã®é¢äžã¯äžååãªããã§ãã
人äºã®DXã¯ãŸã ãããã
ããŒãœã«ç·åç ç©¶æã®èª¿æ»ã§ã¯ã人æãããžã¡ã³ãã®ããžã¿ã«æŽ»çšãäŒæ¥ã®34.5ïŒ ããç©æ¥µçã«é²ããæ¹ããããšæããã41.0ïŒ ãããŸãé²ããæ¹ããããšæãããšåçããŸãããã€ãŸãã75.5ïŒ ãæšé²æŽŸã§ãã
åºå
žïŒããŒãœã«ç·åç ç©¶æ / 人æãããžã¡ã³ãã«ãããããžã¿ã«æŽ»çšã«é¢ãã調æ»çµæãçºè¡š
ãšãããããçµå¶ããããããžã¿ã«æŽ»çšã«ç©æ¥µçã«é¢äžããŠãããã¯42.8ïŒ ããããžã¿ã«æŽ»çšã«é¢ããååãªäºç®ã確ä¿ãããŠãããã¯31.3ïŒ ãã人æã«é¢ããããŒã¿ã®æŽ»çšãæšé²ããäœå¶ãæŽã£ãŠãããã¯29.0ïŒ ã«ãšã©ãŸããŸããäººäºæ¥åã§ããžã¿ã«æŽ»çšãå¿ èŠãšåãæ¢ããããŠããŠããå®éã®DXã¯ãŸã ããããã§ãã
åºå
žïŒããŒãœã«ç·åç ç©¶æ / 人æãããžã¡ã³ãã«ãããããžã¿ã«æŽ»çšã«é¢ãã調æ»çµæãçºè¡š
COVID-19ã®åœ±é¿ã§ãã¬ã¯ãŒã¯ãåºãŸãããã¬ã¯ãŒã¯ãšçžæ§ã®è¯ãããšãããžã§ãåéçšå¶åºŠãæ¡çšããäŒæ¥ãå¢ããŠããŸãããžã§ãåéçšã®å Žåã察象ãšããæ¥åã§æ±ããããç¥èãèœåããã人æãã©ãããèŠæ¥µããªããã°ãªããŸãããäŒæ¥å ã®äººæãè©äŸ¡ããŠãé©åãªæ¥åã§æŽ»èºããŠãããã«ã¯ãèšå€§ãªäººäºããŒã¿ãå€è§çã«åæããŠæŽ»çšããã¿ã¬ã³ããããžã¡ã³ãã·ã¹ãã ã®å©ããå¿ èŠã§ãããã
ããŸããŸãªå Žé¢ã§ããžã¿ã«åã®æ©éãé«ãŸã£ãŠããä»ã¯ã人äºéšéã®DXæšé²ã®ãã£ã³ã¹ãšãããŸãã


